ACO Name and Location

Privia Quality Network, LLC
950 N Glebe Rd
Suite 700
Arlington, VA 22203

ACO Primary Contact

Mark Lamm
Phone: 571-366-8850
Email: mark.lamm@priviahealth.com

Organizational Information

ACO Participants:
ACO ParticipantsACO Participant In Joint Venture
Accessible Physician Home Care, LLCN
Allergy And Asthma Clinic Of MarylandN
Anchor Healthcare PLCN
Anju Verma MD PCN
Bay West Endocrinology Associates PAN
Best Health Services PCN
Christina Braun MD PCN
Comprehensive Neurology And Sleep Medicine, P.A.N
Denise Chevalier HamiltonN
Dr. Helbing Allergy & Asthma Associates LTDN
Felice Physical TherapyN
Forsyth Medical Group, LLCN
Fredericksburg Primary Care, P.C.N
Healthcare For Women PCN
Inpatient Surgical Consultants PAN
Lawrence MillerN
Matthews Internal Medicine PLLCN
Metro Orthopedics & Sports TherapyN
Mount Vernon Internal MedicineN
Nephrology & Hypertension Of Virginia, PLLCN
New Hope Family Medicine PAN
Newbridge Spine And Pain Center LLCN
Next Journey Orthopaedics PLLCN
Northern Virginia Gastroenterology, PCN
Northern Virginia Physicians To Women, LTD.N
Ortho OIC Orthopaedic Immediate Care LLCN
Premier Internal Medicine & Urgent Care, P.L.L.C.N
Primedocs PCN
Prismamed Services LLCN
Privia Medical Group LLCN
Randleman Medical CenterN
Randolph Pulmonary & Sleep Clinic, PLLCN
Richard A. Dougherty, MD, PAN
Telegraph Corner Family Medicine PCN
VCM Family MedicineN
Virginia Womens Center INCN
William D. Hunter, MD PAN
ACO Governing Body:
Member First NameMember Last NameMember Title / PositionMember’s Voting Power (%)Membership TypeACO Participant Legal Business NameACO Participant DBA, if applicable
KeithBerkleChairman10%ACO ParticipantPrivia Medical Group LLCN/A
JaneBelfordDirector10%Beneficiary RepresentativeN/AN/A
StephanieCarterDirector10%ACO ParticipantPrivia Medical Group LLCN/A
CoreyPerdueDirector10%OtherN/AN/A
HabibChotaniDirector10%ACO ParticipantPrivia Medical Group LLCN/A
ThomasEppesDirector10%ACO ParticipantPrivia Medical Group LLCN/A
Ann MarieGordonDirector10%ACO ParticipantPrivia Medical Group LLCN/A
CatieZanerDirector10%ACO ParticipantPrivia Medical Group LLCN/A
DavidWestDirector10%ACO ParticipantPrivia Medical Group LLCN/A
LindaPowersDirector10%ACO ParticipantPrivia Medical Group LLCN/A
Key ACO Clinical and Administrative Leadership:
  • ACO Executive: Corey Perdue
  • Medical Director: Jarrett Dodd, MD
  • Compliance Officer: Stephanie Clark
  • Quality Assurance/Improvement Officer: David West
Associated Committees and Committee Leadership:
Committee NameCommittee Leader Name & Position
Clinical IT CommitteeJarret Dodd, Chair
Clinical Performance CommitteeDavid West, Chair
Compliance CommitteeCaroline Huang, Chair
Credentialing CommitteeHabib Chotani, Chair
Finance CommitteeSumi Sexton, Chair
Types of ACO participants, or combinations of participants, that formed the ACO:
  • ACO professionals in a group practice arrangement
  • Networks of individual practices of ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses
  • Third Agreement Period
    • Performance Year 2024: $56,874,293
    • Performance Year 2023: $51,566,511
    • Performance Year 2022: $44,130,899
    • Performance Year 2021: $41,642,012
    • Performance Year 2020: $42,266,717
  • Second Agreement Period
    • Performance Year 2019: $16,998,165
    • Performance Year 2018: $20,066,830
    • Performance Year 2017: $18,079,932
  • First Agreement Period
    • Performance Year 2016: $0
    • Performance Year 2015: $6,156,225
    • Performance Year 2014: $2,793,592
Shared Savings Distribution
  • Third Agreement Period
    • Performance Year 2024
      • Proportion invested in infrastructure: 30%
      • Proportion invested in redesigned care processes/resources: 10%
      • Proportion of distribution to ACO participants: 60%
    • Performance Year 2023
      • Proportion invested in infrastructure: 30%
      • Proportion invested in redesigned care processes/resources: 10%
      • Proportion of distribution to ACO participants: 60%
    • Performance Year 2022
      • Proportion invested in infrastructure: 30%
      • Proportion invested in redesigned care processes/resources: 10%
      • Proportion of distribution to ACO participants: 60%
    • Performance Year 2021
      • Proportion invested in infrastructure: 30%
      • Proportion invested in redesigned care processes/resources: 10%
      • Proportion of distribution to ACO participants: 60%
    • Performance Year 2020
      • Proportion invested in infrastructure: 30%
      • Proportion invested in redesigned care processes/resources: 10%
      • Proportion of distribution to ACO participants: 60%
  • Second Agreement Period
    • Performance Year 2019
      • Proportion invested in infrastructure: 30%
      • Proportion invested in redesigned care processes/resources: 10%
      • Proportion of distribution to ACO participants: 60%
    • Performance Year 2018
      • Proportion invested in infrastructure: 30%
      • Proportion invested in redesigned care processes/resources: 10%
      • Proportion of distribution to ACO participants: 60%
    • Performance Year 2017
      • Proportion invested in infrastructure: 30%
      • Proportion invested in redesigned care processes/resources: 10%
      • Proportion of distribution to ACO participants: 60%
  • First Agreement Period
    • Performance Year 2016
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
    • Performance Year 2015
      • Proportion invested in infrastructure: 30%
      • Proportion invested in redesigned care processes/resources: 10%
      • Proportion of distribution to ACO participants: 60%
    • Performance Year 2014
      • Proportion invested in infrastructure: 30%
      • Proportion invested in redesigned care processes/resources: 10%
      • Proportion of distribution to ACO participants: 60%

Quality Performance Results

2024 Quality Performance Results:

Quality Performance Results are based on CMS Web Interface Measure Set

Measure #Measure NameCollection TypeReported Performance RateCurrent Year Mean Performance Rate (SSP ACOs)
Measure # 001Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%)CMS Web Interface4.429.44
Measure # 134Preventative Care and Screening: Screening for Depression and Follow-up PlanCMS Web Interface86.3781.46
Measure # 236Controlling High Blood PressureCMS Web Interface85.1079.49
Measure # 318Falls: Screening for Future Fall RiskCMS Web Interface93.0688.99
Measure # 110Preventative Care and Screening: Influenza ImmunizationCMS Web Interface83.8068.60
Measure # 226Preventative Care and Screening: Tobacco Use: Screening and Cessation InterventionCMS Web Interface100.0079.98
Measure # 113Colorectal Cancer ScreeningCMS Web Interface85.4577.81
Measure # 112Breast Cancer ScreeningCMS Web Interface77.8080.93
Measure # 438Statin Therapy for the Prevention and Treatment of Cardiovascular DiseaseCMS Web Interface83.3386.50
Measure # 370Depression Remission at Twelve MonthsCMS Web Interface30.6717.35
Measure # 321CAHPS for MIPSCMS Web Interface4.626.67
Measure # 479Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS GroupsCMS Web Interface0.14570.1517
Measure # 484Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic ConditionsCMS Web Interface---37.00
CAHPS-1Getting Timely Care, Appointments, and InformationCAHPS for MIPS Survey82.6883.70
CAHPS-2How Well Providers CommunicateCAHPS for MIPS Survey92.7193.96
CAHPS-3Patient’s Rating of ProviderCAHPS for MIPS Survey91.5392.43
CAHPS-4Access to SpecialistsCAHPS for MIPS Survey70.4375.76
CAHPS-5Health Promotion and EducationCAHPS for MIPS Survey67.2565.48
CAHPS-6Shared Decision MakingCAHPS for MIPS Survey59.7162.31
CAHPS-7Health Status and Functional StatusCAHPS for MIPS Survey74.8574.14
CAHPS-8Care CoordinationCAHPS for MIPS Survey84.4385.89
CAHPS-9Courteous and Helpful Office StaffCAHPS for MIPS Survey91.7392.89
CAHPS-11Stewardship of Patient ResourcesCAHPS for MIPS Survey22.1926.98
  • *For Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%) [Quality ID #001], Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Eligible Clinician Groups [Measure #479], and Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions (MCC) [Measure #484], a lower performance rate indicates better measure performance.
  • *For Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions (MCC) [Measure #484], patients are excluded if they were attributed to Qualifying Alternative Payment Model (APM) Participants (QPs). Most providers participating in Track E and ENHANCED track ACOs are QPs, and so performance rates for Track E and ENHANCED track ACOs may not be representative of the care provided by these ACOs' providers overall. Additionally, many of these ACOs do not have a performance rate calculated due to not meeting the minimum of 18 beneficiaries attributed to non-QP providers.

For Previous Years’ Financial and Quality Performance Results, Please Visit data.cms.gov